- Home
- STRO vs CHMI Comparison
STRO vs CHMI Comparison
Compare STRO & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- CHMI
- Stock Information
- Founded
- STRO 2003
- CHMI 2012
- Country
- STRO United States
- CHMI United States
- Employees
- STRO N/A
- CHMI N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- CHMI Real Estate Investment Trusts
- Sector
- STRO Health Care
- CHMI Real Estate
- Exchange
- STRO Nasdaq
- CHMI Nasdaq
- Market Cap
- STRO 94.9M
- CHMI 83.3M
- IPO Year
- STRO 2018
- CHMI 2013
- Fundamental
- Price
- STRO $0.89
- CHMI $2.40
- Analyst Decision
- STRO Hold
- CHMI Hold
- Analyst Count
- STRO 7
- CHMI 3
- Target Price
- STRO $1.97
- CHMI $2.75
- AVG Volume (30 Days)
- STRO 782.2K
- CHMI 304.5K
- Earning Date
- STRO 11-06-2025
- CHMI 11-06-2025
- Dividend Yield
- STRO N/A
- CHMI 16.95%
- EPS Growth
- STRO N/A
- CHMI N/A
- EPS
- STRO N/A
- CHMI 0.02
- Revenue
- STRO $105,646,000.00
- CHMI $40,202,000.00
- Revenue This Year
- STRO $65.48
- CHMI N/A
- Revenue Next Year
- STRO N/A
- CHMI $52.49
- P/E Ratio
- STRO N/A
- CHMI $125.96
- Revenue Growth
- STRO N/A
- CHMI N/A
- 52 Week Low
- STRO $0.52
- CHMI $2.17
- 52 Week High
- STRO $3.01
- CHMI $3.68
- Technical
- Relative Strength Index (RSI)
- STRO 48.24
- CHMI 55.02
- Support Level
- STRO $0.81
- CHMI $2.20
- Resistance Level
- STRO $0.95
- CHMI $2.42
- Average True Range (ATR)
- STRO 0.08
- CHMI 0.10
- MACD
- STRO -0.00
- CHMI 0.01
- Stochastic Oscillator
- STRO 53.02
- CHMI 74.92
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.